|
2024
|
Invention
|
Codon-optimized human npc1 genes for the treatment of niemann-pick type c1 deficiency and related... |
|
|
Invention
|
Dopamine d3 receptor selective antagonists/partial agonists and uses thereof.
Disclosed herein a... |
|
|
Invention
|
Identification of novel sequences of the ervmer34-1 human endogenous retroviral sequence family, ... |
|
|
Invention
|
Kinase inhibitors. Disclosed is a class of kinase inhibitors of formula (I) or formula (II). Rela... |
|
|
Invention
|
2b serotonin receptor antagonists, pharmaceutical compositions thereof, and methods of use thereo... |
|
|
Invention
|
Fully human monoclonal antibodies and chimeric antigen receptors against cd276 for the treatment ... |
|
|
Invention
|
Humanized 40h3 antibody. e.ge.g., humanized monoclonal antibodies and antigen binding fragments) ... |
|
|
Invention
|
Uses of iron chelators for treating stuttering. Provided herein are uses of iron chelators to tre... |
|
|
Invention
|
Potent and selective dopamine d3 receptor antagonists. 33 receptor modulators, inclusive of antag... |
|
|
Invention
|
Shipping container for system supporting live cells. A shipping container for the support and shi... |
|
|
Invention
|
Genetically detoxified mutant of neisseria and outer membrane vesicle (omv) vaccine. Disclosed ar... |
|
|
Invention
|
Novel malaria vaccine comprising ama1 and ron2 antigens. Plasmodium yoeliiPlasmodium falciparumPl... |
|
|
Invention
|
T cell receptors targeting ras with g12d, g12r, or g12v mutation. Disclosed are isolated or purif... |
|
|
Invention
|
Epidithiodiketopiperazine analogs and methods of use. Epidithiodiketopiperazine (ETP) analogs and... |
|
|
Invention
|
Method and apparatus for cryogenic-electron microscopy sample preparation. An apparatus for prepa... |
|
|
Invention
|
Formulations and methods for the prevention and treatment of tumor metastasis and tumorigenesis. ... |
|
|
Invention
|
Vaccine for cats to block toxoplasma oocyst shedding and transmission. Apicomplexa or EuglenozoaT... |
|
|
Invention
|
Hiv-1 envelope triple tandem trimers and their use. Immunogens comprising a recombinant HIV-1 Env... |
|
|
Invention
|
Copiparvovirus genetic vector platform. In a first aspect, the invention provides a genetic vecto... |
|
|
Invention
|
Tyrosinase gene therapy for oculocutaneous albinism type 1a. TyrosinaseBESTROPHINVMD2TyrosinaseTy... |
|
|
Invention
|
Human monoclonal antibodies that target the rh5 complex of blood-stage plasmodium falciparum. P. ... |
|
|
Invention
|
Recombinant murine pneumonia virus expressing severe acute respiratory syndrome coronavirus 2 (sa... |
|
|
Invention
|
Single domain antibodies that specifically bind the s2 subunit of sars-cov-2 spike protein and co... |
|
|
Invention
|
Treatment of hypoparathyroidism using triphenyl calcilytic compounds. The present disclosure prov... |
|
|
Invention
|
Systems and methods for multichannel individualized stimulation therapy. Methods and systems are ... |
|
|
Invention
|
Synthetic mmab genes and aav vectors to treat cobalamin b deficiency. synMMABsynMMABsynMMAB polyn... |
|
|
Invention
|
Systems and methods for patterned multi-slice excitation in magnetic resonance imaging. Various m... |
|
|
Invention
|
Methods of preparing an isolated population of dendritic cells and methods of treating cancer usi... |
|
|
Invention
|
1-thioxo-2,4-dihydrothieno[2,3-e][1,2,4]triazolo[4,3-a]pyrimidin-5(1 h)-one derivatives as allost... |
|
|
Invention
|
Methods for enhancing the immunogenicity of cellular vaccines. The present disclosure provides en... |
|
|
Invention
|
Enzymatic radiosynthesis of deoxy-[18f]fluorocellobiose and deoxy-[18f]fluorocellotriose. Enzymat... |
|
|
Invention
|
T cell receptors targeting y220c or r175h mutation in p53. Disclosed are isolated or purified T c... |
|
|
Invention
|
Methods for treatment of age-related macular degeneration. Methods are disclosed for treating or ... |
|
|
Invention
|
Methods for producing stable human chondroctyes and their use for promoting cartillage growth and... |
|
|
Invention
|
Devices and methods. The present invention provides devices and methods for electroporation. Embo... |
|
|
Invention
|
System and protocol for monitoring pregnancy health. The disclosure provides systems and a protoc... |
|
|
Invention
|
Detection of hepatitis c virus ribonucleic acid from whole blood using reverse transcription loop... |
|
|
Invention
|
Dual-target mu opioid and dopamine d3 receptors ligands preparation and use thereof. 3333R antago... |
|
|
Invention
|
Composition for preventing or treating systemic capillary leak syndrome. The present invention pe... |
|
|
Invention
|
Mutant ara h 2 and ara h 6 proteins and uses thereof. Provided herein are hypoallergenic mutant A... |
|
|
Invention
|
Recombinant adeno-associated virus vectors lacking an immunodominant t cell epitope and use there... |
|
|
Invention
|
Systems and methods for introducing samples to open port interface.
A method of processing a sam... |
|
|
Invention
|
Methods of preparing anti-human papillomavirus antigen t cells.
Disclosed are methods of prepari... |
|
|
Invention
|
Systems and methods for deep learning to detect retinal vasculitis on color fundus photographs of... |
|
|
Invention
|
Epstein-barr virus glycoprotein 42 immunogens for vaccination and antibody discovery. Modified Ep... |
|
2023
|
Invention
|
Fluorinated mu-opioid receptor agonists. The invention provides a fluorinated compound of Formula... |
|
2022
|
Invention
|
Aqp1 gene therapy to prevent radiation induced salivary hypofunction.
Administration of aquapori... |
|
2021
|
Invention
|
Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteins... |
|
|
Invention
|
Exo vii inhibitor and quinolone antibiotic combination useful for treating bacterial infection.
... |
|
|
Invention
|
Therapeutics for the treatment of neurodegenerative disorders.
Antisense oligonucleotides (ASOs)... |
